Greater Cincinnati remains Ohio’s political war chest when it comes to generating contributions for the 2008 presidential candidates.

Chong Ahn considers himself a scholar, not a businessman. And yet his ability to figure out what might sell has him about to open a nearly 8,000-square-foot manufacturing facility in Forest Park.

There is a debate in Congress that could have a great impact on the bioscience industry in Maryland. Congress is poised to legislate the approval process for “follow-on biologics,” or third-party imitations of innovative biologic products. Biologics are the most advanced and complex of all medicines — essentially, proteins made by living cells that grow in vats similar to how wine is made. After debating the approval process for biologics, Congress is likely to establish guidelines that could profoundly impact the levels of bioscience research.

Several hundred are expected to honor biotech pioneer Dr. Lee Hood when he turns 70.

SOUTHAMPTON, UK and EUGENE, OR (MARKET WIRE) A consortium led by ultrafast fiber laser manufacturer Fianium is to develop and evaluate advanced white-light (supercontinuum) fiber lasers for biomedical imaging applications.

One of my pet peeves as a scientist is when research results are misquoted by media as having proved or disproved something, or when people without a science background quote...

CINCINNATI, OH (MARKET WIRE) UMD, Inc., a Cincinnati drug delivery company, today announced the filing of U.S. Patent Application Serial No. 12/130,279. The application deals with pH modulated films for delivery of actives. This application is very similar to one filed by MonoSol Rx on December 14, 2006, which published as U.S. Patent Application No. 2007/0149731 A1 on June 28, 2007.

NEW YORK, NY (MARKET WIRE) Since AIDS was first recognized in 1981, significant advances have been made in developing an effective arsenal of drugs to manage the disease and extend patients' lives. However, HIV's ability to mutate and become resistant to current drugs is a persistent threat, and many patients don't benefit from or cannot tolerate complex combination regimens. According to a new report from Kalorama Information entitled "HIV: Markets for Diagnostics and Therapeutics," research is underway to develop more potent therapies that have fewer toxic effects and are easier to administer, including a new

HERCULES, CA (MARKET WIRE) Bio-Rad Laboratories, Inc. (AMEX: BIO) and (AMEX: BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, will report financial results for the third quarter 2008 on Thursday, November 6, 2008, after the close of the market. The company will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.

Invest Southwest has chosen 13 companies from Arizona, Mexico, Utah and New Mexico to present their business plans at this year’s conference in December.